Emerging Cannabinoid Products in Europe: Transparency, Testing and Regulatory Challenges in 2026

Europe’s cannabinoid market is changing quickly. Alongside established CBD products, consumers are increasingly encountering new commercial names, new formulations and products positioned around recently introduced cannabinoids. This creates a basic problem for both retailers and buyers: a commercial name does not necessarily tell the consumer what a substance is, how it was produced or how […]